The Role of Integrin Beta 3 Polymorphisms in Coronary Artery Disease: A Systematic Review and Meta-analysis

Abstract

Objectives: The literature on the role of integrin beta 3 (ITGB3) exonic variants in coronary artery disease (CAD) and lipid outcomes is scarce. However, the findings remained uncertain and still not clear. Therefore, the current study aims to determine the association of rs5918 polymorphism with coronary artery disease. Methodology: All the eligible literature published in the English language from February 3, 2005, up to December 19, 2021, were searched by using different electronic databases and extracted all the required information from the available literature. The statistical analysis was performed through the MetaGenyo program, and pooled odds ratios (ORs) were calculated to determine the association between rs5918 and CAD. Results: The final analysis includes four studies, and the overall rs5918 risk allele in all the tested genetic models as follow: allelic model: OR 0.80 CI 0.41-1.58; homozygote model: OR 1.66, 95% CI 0.20-2.16; recessive model: OR 0.71 CI 0.44-1.14; dominant model: OR 0.81 CI 0.22-3.03. In addition, the lipid outcomes, including lipoproteins, cholesterol, and triglycerides were associated with increased disease risk. The shapes of the funnel plots suggest no publication bias in our study. Conclusion: In conclusion, our final pooled analysis revealed a non-significant role of this exonic polymorphism in coronary artery disease that may exert its effect by modulating various lipid parameters. However, more studies are required with a larger cohort size that may give us conclusive results in the future.